Abrdn Healthcare Investors (HQH) NYSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
100 Federal Street
Philadelphia, PA 02110
United States of America (the)
Phone
215 405 5700
Sector
Financial Services
Industry
Asset Management
Employees
N/A
First IPO Date
April 23, 1987
| Name | Title | Pay | Year Born |
| Frank T. Gentile | Senior Vice President of Research and Portfolio Manager | 0 | 1962 |
| Daniel R. Omstead | Portfolio Manager | 0 | 1953 |
| Christopher F. Brinzey | Senior Vice President of Research and Portfolio Manager | 0 | N/A |
| Jason C. Akus | Vice President of Research and Portfolio Manager | 0 | N/A |
Abrdn Healthcare Investors is a closed-end equity fund, stewarded by abrdn Inc. Its mandate involves global public equity investments, specifically targeting the healthcare sector, encompassing businesses in biotechnology, medical devices, and pharmaceuticals. The primary focus is on high-growth, small-capitalization companies. The portfolio is constructed using a fundamental analysis approach, scrutinizing companies based on their current or projected market position for products and services, the experience of their management teams, their technological prowess, and their capability to either self-fund growth or secure external financing. Its performance is measured against several benchmarks: the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Established on October 31, 1986, the fund is domiciled in the United States.